Alert detail

LCD L39832: Botulinum Toxin Injections — NGS

Policy ID: LCD-L39832Specialty: Pain ManagementAdded: 6/5/2026Effective: February 22, 2026lcd
High

What changed

New LCD on Botulinum Toxin Injections impacts billing.

Who’s affected: Pain Management billing teams · Effective: February 22, 2026

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 34 billing codes.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of Pain Management policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Pain Management audit pack — $349One-time purchase · not a subscription

Not ready to subscribe?

Get the free weekly reimbursement brief for Pain Management— the week’s changes and deadlines, delivered to your inbox. No account required.